Published on 7 Sep 2023 on The Business Journals
The Petri Dish: Biogen secures $1.5B loan; Mersana CEO departs after trial failure - Boston Business...
Biogen Inc. (Nasdaq: BIIB) will be financing its upcoming acquisition of Reata Pharmaceuticals Inc....
Reata Pharmaceuticals, Inc. (NASDAQ:RETA) Is Expected To Breakeven In The Near Future
Reata Pharmaceuticals, Inc. (NASDAQ:RETA) is possibly approaching a major achievement in its busi...
Insider Sell: SVP, Chief Accounting Officer Bhaskar Anand Sells 406 Shares of Reata ...
On September 5, 2023, Bhaskar Anand, the SVP, Chief Accounting Officer of Reata Pharmaceuticals I...
The Petri Dish: Biogen secures $1.5B loan; Mersana CEO departs after trial failure - Boston Business...
Biogen Inc. (Nasdaq: BIIB) will be financing its upcoming acquisition of Reata Pharmaceuticals In...
Top Stocks for September 2023
Further, as other investors pile on to bid on shares of these companies, they help to push their ...
5 Biotech Stocks to Buy as New Drug Approvals Drive Industry Prospects
After a decent performance in the first half of 2023, the outlook for the second half of 2023 for...
Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?
Designed to provide broad exposure to the Healthcare - Pharma segment of the equity market, the S...
BOXER CAPITAL, LLC Boosts Stake in Mirati Therapeutics Inc
BOXER CAPITAL, LLC, a San Diego-based investment firm, recently increased its holdings in Mirati ...
Alimera Sciences (ALIM) Reports Q2 Loss, Lags Revenue Estimates
Alimera Sciences (ALIM) came out with a quarterly loss of $0.44 per share versus the Zacks Consen...
Entrada Therapeutics, Inc. (TRDA) Reports Q2 Loss, Misses Revenue Estimates
Entrada Therapeutics, Inc. (TRDA) came out with a quarterly loss of $0.78 per share versus the Za...
CPMG Inc Acquires Significant Stake in Reata Pharmaceuticals Inc
CPMG Inc (Trades, Portfolio), a prominent investment firm, recently expanded its portfolio with t...